Filtered By:
Therapy: Cancer Therapy
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 225 results found since Jan 2013.
Soluble and Immobilized Anti-CD3/28 Distinctively Expand and Differentiate Primary Human T Cells: An Implication for Adoptive T Cell Therapy
In conclusion, our data demonstrated that the soluble CD3/28 mAbs protocol is cost-effective and more efficient for generating more potent T cells, thereby expecting a better therapeutic outcome.PMID:36640054 | DOI:10.18502/ijaai.v21i6.11521
Source: Iranian Journal of Allergy, Asthma and Immunology - January 14, 2023 Category: Allergy & Immunology Authors: Tahereh Soltantoye Behnia Akbari Hamid Reza Mirzaei Jamshid Hadjati Source Type: research
